Skip to main content
Articles & Publications , Thierry Van Nieuwenhove

Thierry Van Nieuwenhove Shares His Insights on Emerging Trends in the CDMO Industry

Thierry Van Nieuwenhove

In this article by Contract Pharma, Thierry Van Nieuwenhove, the CEO of Quotient Sciences discusses how the CDMO is positioning itself to stay ahead of the curve and what are the most significant trends in the CDMO industry. 

Thierry also talks about the business highlights from the past 12-24 months and how the Quotient Sciences is integrating new technologies and innovations in its processes.

Continue reading the full article or watching the video on Contract Pharma.

Latest news from Quotient Sciences

More News
Articles & Publications, Dr. Andy Lewis, AI, Clinical Trials The Future of Pharma: How AI is Transforming the Industry By: Dr. Andrew Lewis
Read More
formulation development, GLP-1, Peptides, Dr. Andy Lewis, Dr. Andrew Parker Video Interview: Dr. Andrew Lewis and Dr. Andrew Parker Speak with Manufacturing Chemist at CPHI Milan
Read More
Get in touch
Humanity can't afford to wait, so neither can we.